Bevacizumab/temozolomideLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1974卷 / 1期

关键词：

D O I：

10.1007/s40278-023-46091-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：80 / 80

相关论文

共 50 条

[1] Bevacizumab/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 95 - 95
[2] Bevacizumab/TemozolomideLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 99 - 99
[3] Bevacizumab/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 104 - 104
[4] Bevacizumab/dexamethasone/temozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 129 - 129
[5] Bevacizumab/lomustine/temozolomideLack of efficacy and pneumonitis: case report
Reactions Weekly, 2022, 1929 (1) : 143 - 143
[6] TemozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 388 - 388
[7] Bevacizumab/Irinotecan/TemozolomideLack of efficacy and veinous thromboembolic events: case report
Reactions Weekly, 2025, 2040 (1) : 180 - 180
[8] Bevacizumab/TemozolomideLack of efficacy
Reactions Weekly, 2024, 2006 (1) : 138 - 138
[9] Bevacizumab/temozolomideLack of efficacy
Reactions Weekly, 2024, 2011 (1) : 89 - 89
[10] Bevacizumab/TemozolomideLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2030 (1) : 98 - 98

← 1 2 3 4 5 →